Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Rosetta Genomics Ltd. (ROSG) Starts Presentation at LD Micro Conference

Rosetta Genomics Ltd. (NASDAQ: ROSG) develops and commercializes a broad range of microRNA-based and other high-value molecular diagnostics. The company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Rosetta is currently working on the application of these technologies in the development and commercialization of a full range of microRNA-based diagnostic tools. For more information, visit the company’s website at

The three-day LD Micro Invitational in Bel Air, California, features company presentations from more than 200 select high-potential small-cap companies spanning multiple industries. Institutional and retail investors in attendance also have access to numerous networking opportunities and social events to learn more about these companies. For more information on LD Micro, visit
This entry was posted in LD Micro Conference. Bookmark the permalink.

Comments are closed.